Cart is empty A new treatment for infant respiratory syncytial virus (RSV)—a leading cause of severe illness in US babies—is 90 percent effective in preventing hospitalization, health authorities said Thursday.
A new treatment for infant respiratory syncytial virus (RSV)—a leading cause of severe illness in US babies—is 90 percent effective in preventing hospitalization, health authorities said Thursday.
Leave A Comment